HST Global Inc (HSTC) financial statements (2021 and earlier)

Company profile

Business Address 150 RESEARCH DR.
HAMPTON, VA 23666
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments  00001
Cash and cash equivalents  00001
Total current assets:  00001
Noncurrent Assets
TOTAL ASSETS:  00001
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 35253059
Interest and dividends payable 377     
Other undisclosed accounts payable and accrued liabilities (373)5253059
Debt 3    1,215
Deferred compensation liability  990870750510390
Due to related parties 2,988506506506506506
Other undisclosed current liabilities 3771,6921,6271,5691,453163
Total current liabilities: 3,3713,1933,0282,8552,4742,282
Noncurrent Liabilities
Total liabilities: 3,3713,1933,0282,8552,4742,282
Stockholders' equity
Stockholders' equity attributable to parent, including: (3,371)(3,193)(3,028)(2,854)(2,474)(2,281)
Common stock 373737373737
Additional paid in capital 2,3852,3852,3852,3852,3852,385
Accumulated deficit (5,792)(5,614)(5,449)(5,276) (4,703)
Other undisclosed stockholders' equity attributable to parent     (4,896) 
Total stockholders' equity: (3,371)(3,193)(3,028)(2,854)(2,474)(2,281)
TOTAL LIABILITIES AND EQUITY:  00001

Income statement (P&L) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2013
12/31/2012
Operating expenses (143)(153)(137)(160)(157)(342)
Other operating income, net
(Other Expenses)
    363534
Other undisclosed operating loss    (36)(35)(34)
Operating loss: (143)(153)(137)(160)(157)(342)
Nonoperating expense (36)     
Interest and debt expense 3612(36)(36)3534
Loss from continuing operations before equity method investments, income taxes: (143)(141)(173)(196)(122)(308)
Other undisclosed loss from continuing operations before income taxes      (68)
Loss from continuing operations before income taxes: (143)(141)(173)(196)(122)(376)
Income tax benefit 3756 67  
Loss before gain (loss) on sale of properties: (105)(85)(173)(129)(122)(376)
Other undisclosed net loss (73)     
Net loss: (178)(85)(173)(129)(122)(376)
Other undisclosed net loss attributable to parent  (80) (67)(71) 
Net loss available to common stockholders, diluted: (178)(165)(173)(196)(193)(376)

Comprehensive Income ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2013
12/31/2012
Net loss: (178)(85)(173)(129)(122)(376)
Comprehensive loss, net of tax, attributable to parent: (178)(85)(173)(129)(122)(376)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: